Pauline Wimberger

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 30

Top Topics

Atrial Fibrillation

Epidermal Growth Factor Receptor

Metastatic Breast Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

The EMBO journal

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Paula Cubillos, Nora Ditzer, Annika Kolodziejczyk, Gustav Schwenk, Janine Hoffmann, Theresa M Schütze, Razvan P Derihaci, Cahit Birdir, Johannes Em Köllner, Andreas Petzold, Mihail Sarov, Ulrich Martin, Katherine R Long, Pauline Wimberger, Mareike Albert
The growth factor EPIREGULIN promotes basal progenitor cell proliferation in the developing neocortex. The EMBO journal (2024)
Paula Cubillos, Nora Ditzer, Annika Kolodziejczyk, Gustav Schwenk, Janine Hoffmann, Theresa M Schütze, Razvan P Derihaci, Cahit Birdir, Johannes Em Köllner, Andreas Petzold, Mihail Sarov, Ulrich Martin, Katherine R Long, Pauline Wimberger, Mareike Albert
The growth factor EPIREGULIN promotes basal progenitor cell proliferation in the developing neocortex. The EMBO journal 43 (8) (2024)
Paula Cubillos, Nora Ditzer, Annika Kolodziejczyk, Gustav Schwenk, Janine Hoffmann, Theresa M Schütze, Razvan P Derihaci, Cahit Birdir, Johannes Em Köllner, Andreas Petzold, Mihail Sarov, Ulrich Martin, Katherine R Long, Pauline Wimberger, Mareike Albert
The growth factor EPIREGULIN promotes basal progenitor cell proliferation in the developing neocortex. The EMBO journal 43 (8) (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Paula Cubillos, Nora Ditzer, Annika Kolodziejczyk, Gustav Schwenk, Janine Hoffmann, Theresa M Schütze, Razvan P Derihaci, Cahit Birdir, Johannes Em Köllner, Andreas Petzold, Mihail Sarov, Ulrich Martin, Katherine R Long, Pauline Wimberger, Mareike Albert
The growth factor EPIREGULIN promotes basal progenitor cell proliferation in the developing neocortex. The EMBO journal (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Paula Cubillos, Nora Ditzer, Annika Kolodziejczyk, Gustav Schwenk, Janine Hoffmann, Theresa M Schütze, Razvan P Derihaci, Cahit Birdir, Johannes Em Köllner, Andreas Petzold, Mihail Sarov, Ulrich Martin, Katherine R Long, Pauline Wimberger, Mareike Albert
The growth factor EPIREGULIN promotes basal progenitor cell proliferation in the developing neocortex. The EMBO journal 43 (8) (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Paula Cubillos, Nora Ditzer, Annika Kolodziejczyk, Gustav Schwenk, Janine Hoffmann, Theresa M Schütze, Razvan P Derihaci, Cahit Birdir, Johannes Em Köllner, Andreas Petzold, Mihail Sarov, Ulrich Martin, Katherine R Long, Pauline Wimberger, Mareike Albert
The growth factor EPIREGULIN promotes basal progenitor cell proliferation in the developing neocortex. The EMBO journal 43 (8) (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Florian Heitz, Christian Marth, Stéphanie Henry, Alexander Reuss, David Cibula, Lydia Gaba Garcia, Nicoletta Colombo, Barbara Schmalfeld, Nikolaus de Gregorio, Pauline Wimberger, Annette Hasenburg, Jalid Sehouli, Martina Gropp-Meier, Philip C Schouten, Eric Hahnen, Jan Hauke, Sandra Polleis, Philipp Harter
AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Pauline Wimberger, Jacobus Pfisterer, Andreas du Bois, Felix Hilpert, Markus Kerkmann, Jalid Sehouli, Sven Mahner, Nikolaus de Gregorio, Lars Hanker, Florian Heitz, Frederik Marmé, Linn Woelber, Laura Holtmann, Gabriele Elser, Philipp Harter, null null
Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Theresa Link, Jens-Uwe Blohmer, Wolfgang Daniel Schmitt, Jan Dominik Kuhlmann, Marianne Just, Michael Untch, Oliver Stotzer, Peter Andreas Fasching, Marc Thill, Mattea Reinisch, Andreas Schneeweiß, Pauline Wimberger, Sabine Seiler, Jens Huober, Christian Jackisch, Kerstin Rhiem, Claus Hanusch, Bruno Valentin Sinn, Valentina Nekljudova, Sibylle Loibl, Carsten Denkert
RANK expression as an independent predictor for response to neoadjuvant chemotherapy in luminal-like breast cancer - a translational insight from the GeparX trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Giorgio Bogani, Isabelle L Ray-Coquard, David Mutch, Ignace Vergote, Pedro T Ramirez, Jaime Prat, Nicole Concin, Natalie Yan Li Ngoi, Robert L Coleman, Takayuki Enomoto, Kazuhiro Takehara, Hannelore G Denys, Domenica Lorusso, Masashi Takano, Satoru Sagae, Pauline Wimberger, Yakir Segev, Se Ik Kim, Jae-Weon Kim, Fernanda Herrera, Andrea Mariani, Rebecca A Brooks, David Tan, Biagio Paolini, Valentina Chiappa, Mariangela Longo, Francesco Raspagliesi, Pierluigi Benedetti Panici, Violante Di Donato, Giuseppe Caruso, Nicoletta Colombo, Sandro Pignata, Gianfranco Zannoni, Giovanni Scambia, Bradley J Monk
Gestational choriocarcinoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Ignace Vergote, José Alejandro Pérez-Fidalgo, Erika Paige Hamilton, Giorgio Valabrega, Toon Van Gorp, Jalid Sehouli, David Cibula, Tally Levy, Stephen Welch, Debra L Richardson, Eva M Guerra, Giovanni Scambia, Stéphanie Henry, Pauline Wimberger, David Scott Miller, Jaroslav Klat, Jerónimo Martínez-Garcia, Francesco Raspagliesi, Bhavana Pothuri, Ignacio Romero, Alice Bergamini, Brian Slomovitz, Fabienne Schochter, Estrid Høgdall, Lorena Fariñas-Madrid, Bradley J Monk, Dayana Michel, Michael G Kauffman, Sharon Shacham, Mansoor Raza Mirza, Vicky Makker, null null
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Anneline Pinson, Lei Xing, Takashi Namba, Nereo Kalebic, Jula Peters, Christina Eugster Oegema, Sofia Traikov, Katrin Reppe, Stephan Riesenberg, Tomislav Maricic, Razvan P Derihaci, Pauline Wimberger, Svante Pääbo, Wieland B Huttner
Human TKTL1 implies greater neurogenesis in frontal neocortex of modern humans than Neanderthals. Science (New York, N.Y.) 377 (6611) (2022)
Marc Thill, Pauline Wimberger, Andrea Grafe, Peter Klare, Kerstin Luedtke-Heckenkamp, Dietmar Reichert, Matthias Zaiss, Katja Ziegler-Löhr, Tanja Eckl, Andreas Schneeweiß
Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T: results from a German non-interventional study (NIS) HELENA (NCT01777958). Breast cancer research and treatment 196 (2) (2022)
Felipe Mora-Bermúdez, Philipp Kanis, Dominik Macak, Jula Peters, Ronald Naumann, Lei Xing, Mihail Sarov, Sylke Winkler, Christina Eugster Oegema, Christiane Haffner, Pauline Wimberger, Stephan Riesenberg, Tomislav Maricic, Wieland B Huttner, Svante Pääbo
Longer metaphase and fewer chromosome segregation errors in modern human than Neanderthal brain development. Science advances 8 (30) (2022)
Pauline Wimberger, Mara Julia Gerber, Jacobus Pfisterer, Kati Erdmann, Susanne Fuessel, Theresa Link, Andreas du Bois, Stefan Kommoss, Florian Heitz, Jalid Sehouli, Rainer Kimmig, Nikolaus de Gregorio, Barbara Schmalfeldt, Tjoung-Won Park-Simon, Klaus Baumann, Felix Hilpert, Marcel Grube, Willibald Schröder, Alexander Burges, Antje Belau, Lars C Hanker, Jan Dominik Kuhlmann
Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Jalid Sehouli, Alexander Mustea, Guelten Oskay-Özcelik, Maren Keller, Rolf Richter, Oliver Tomé, Hannah Woopen, Ann-Katrin Sommer-Joos, Jacek P Grabowski, Robert Armbrust, Pauline Wimberger
Bevacizumab Combined with Platinum-Taxane Chemotherapy as First-Line Treatment for Advanced Ovarian Cancer: Results of the NOGGO Non-Interventional Study (OTILIA) in 824 Patients. Cancers 13 (19) (2021)
Fabian Trillsch, Sven Mahner, Bastian Czogalla, Miriam Rottmann, Radoslav Chekerov, Elena Ioana Braicu, Gülten Oskay-Öczelik, Pauline Wimberger, Rolf Richter, Jalid Sehouli
Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group. Journal of gynecologic oncology 32 (3) (2021)
Stephan R Künzel, Maximilian Hoffmann, Silvio Weber, Karolina Künzel, Susanne Kämmerer, Mario Günscht, Erik Klapproth, Johanna S E Rausch, Mirna S Sadek, Tomasz Jan Kolanowski, Stefanie Meyer-Roxlau, Christopher Piorkowski, Sems M Tugtekin, Stefan Rose-John, Xiaoke Yin, Manuel Mayr, Jan Dominik Kuhlmann, Pauline Wimberger, Konrad Grützmann, Natalie Herzog, Jan-Heiner Küpper, Molly O'Reilly, S Nashitha Kabir, Laura C Sommerfeld, Kaomei Guan, Ben Wielockx, Larissa Fabritz, Stanley Nattel, Ursula Ravens, Dobromir Dobrev, Michael Wagner, Ali El-Armouche
Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial Fibrillation. Circulation research 129 (8) (2021)
Sherko Kuemmel, Mario Campone, Delphine Loirat, Rafael Lopez Lopez, J Thaddeus Beck, Michelino De Laurentiis, Seock-Ah Im, Sung-Bae Kim, Ava Kwong, Guenther G Steger, Esther Zamora Adelantado, Fran Ois P Duhoux, Richard Greil, Irene Kuter, Yen-Shen Lu, Ariadna Tibau, Mustafa Özgüroğlu, Claus-Jürgen Scholz, Christian F Singer, Estela Vega, Pauline Wimberger, Claudio Zamagni, Xuan-Mai Couillebault, Liqiong Fan, Nelson Guerreiro, Jennifer Mataraza, Janna Sand-Dejmek, Arlene Chan
A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Margarita Melnikova, Ulrike Sophie Wauer, Diana Mendus, Ralf Axel Hilger, Trudy G Oliver, Kim Mercer, Björn Oliver Gohlke, Kati Erdmann, Dieter Niederacher, Hans Neubauer, Paul Buderath, Pauline Wimberger, Jan Dominik Kuhlmann, Juergen Thomale
Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells. Molecular oncology 14 (4) (2020)
Laura L Michel, Andreas D Hartkopf, Peter Andreas Fasching, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Diana Lüftner, Markus Wallwiener, Volkmar Mueller, Matthias W Beckmann, Erik Belleville, Bernhard Volz, Hanna Huebner, Pauline Wimberger, Carsten Hielscher, Christoph Mundhenke, Christian Kurbacher, Rachel Wuerstlein, Michael Untch, Friedrich Overkamp, Jens Huober, Wolfgang Janni, Florin-Andrei Taran, Michael P Lux, Diethelm Wallwiener, Sara Yvonne Brucker, Andreas Schneeweiss, Tanja N Fehm
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab. Cancers 12 (10) (2020)